Las Vegas, NV -- (SBWIRE) -- 10/05/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: BioScrip Inc (NASDAQ:BIOS), Covidien plc (NYSE:COV), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Quest Diagnostics Inc (NYSE:DGX)
BioScrip Inc (NASDAQ:BIOS) managed to keep its gain at 0.35% on above-normal volume of 1.97M shares. The stock settled at $8.52 after floating in a range of $8.44 to $8.64. Its latest price has reached market capitalization of $577.48 million. Its 52-week range has been $8.29 to $17.62. BioScrip, Inc. (BioScrip) is a provider of pharmacy and home health services, which partners with patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and the delivery of prescription medications and home health services. Its platform provides service capabilities and the ability to deliver clinical management services.
For How Long BIOS will fight for Profitability? Read This Trend Analysis report
Covidien plc (NYSE:COV) traded down on a volume of 1.94 million, lower than its standard daily volume. Shares have dropped-0.38% to $60.30. Over the last twelve months, the stock has gained 1.48% and faced a worst price of $53.36. Covidien Public Limited Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings.
Has COV Found The Bottom And Ready To Gain Momentum? Find Out Here
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) settled 3.43% higher at $2.11 on above-normal volume of 1.90M shares during the last trading day. The stock has its 12-month high at $10.37 and 52-week low price was $2.03. It traded in a range of $2.04 to $2.23 during the last trading day. AVEO Pharmaceuticals, Inc. is a cancer therapeutics company discovering, developing and commercializing targeted cancer therapies.
Why Should Investors Buy AVEO After the Recent Fall? Just Go Here and Find Out
In the last trading session, Quest Diagnostics Inc (NYSE:DGX) was down on high volume, trading at a volume of 1.90M versus its average daily volume of 1.25 million shares. At $61.80, the stock has attained market capitalization of 9.39 billion. Quest Diagnostics Incorporated (Quest Diagnostics), is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions.
Why Should Investors Buy DGX After the Recent Fall? Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)